packageDistigmine

distigmine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Distigmine is an acetylcholinesterase inhibitor that has been used to treat myasthenia gravis and neurogenic bladder. It is considered investigational and is not an approved medicine in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27149809 and the WHO ATC classification; not checked by a person.

name:distigmine
ATC codes:N07AA03
DrugBank:DB13694
PubChem CID:3116
ChEBI:80756
Wikidata:Q27149809
formula:C22H32N4O4+2
molar mass:416.522 g/mol (PubChem CID 3116)
logP:2.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown